Industry

DUBLIN–(BUSINESS WIRE)–The “Sepsis Diagnostics Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Product, Technology, Method, Test Type, Pathogen, and End User” report has been added to ResearchAndMarkets.com’s offering. The global sepsis diagnostics market is projected to reach US$ 1,226.52 million by 2028 from US$ 661.83 million in 2021; it is expected to … [Read more…]

Health system enters two-year national partnership to promote mental wellbeing and resiliency of first responders and frontline caregivers NASHVILLE, Tenn.–(BUSINESS WIRE)–HCA Healthcare, Inc. (NYSE: HCA), one of the nation’s leading healthcare providers, today announced a $600,000 grant to Volunteers of America (VOA) through the HCA Healthcare Foundation and its Healthier Tomorrow Fund to promote mental … [Read more…]

One of the largest manufacturing sites for the company, the $105 million facility adds capacity to enable more life-saving vaccines and therapies WALTHAM, Mass.–(BUSINESS WIRE)–Thermo Fisher Scientific Inc., the world leader in serving science, today opened its largest single-use technology manufacturing site in Greater Nashville. The $105 million, 400,000-square-foot facility enables the company to help … [Read more…]

CSRI leaders are facilitating conversations about the health data utility model SAN ANTONIO–(BUSINESS WIRE)–#HIE–Leaders with the Consortium for State and Regional Interoperability (CSRI), a collection of the nation’s largest and most robust nonprofit health data networks, will drive dialogue about the health data utility model (thecsri.org/health-data-utility) at The Civitas 2022 Annual Conference, a Collaboration with … [Read more…]

CHICAGO–(BUSINESS WIRE)–MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today reported financial results for the second quarter ended June 30, 2022, and provided a corporate update. “We continue to make significant progress with advancing the clinical development of THIO. We recently dosed the first patient … [Read more…]

DALLAS–(BUSINESS WIRE)–#Digitalhealth—Recuro Health (Recuro), a premier virtual health solutions company that takes a uniquely personalized and proactive approach to virtual care through its Digital Medical Home™ (DMH), today announces the acquisition of Competitive Health (CHI), an integrated digital health solutions company that provides a suite of digital products to help employers reduce costs, promote engagement … [Read more…]

Company expanding micro-fine glass fiber capacity in US, Europe, and China to support future growth BUFFALO, N.Y.–(BUSINESS WIRE)–Alkegen, one of the largest specialty materials platforms in the world that provides high performance materials used in advanced applications including filtration media, battery technologies, high temperature insulation and fire protection, today announced expansion efforts aimed at increasing … [Read more…]

Novel NMR Probe Technologies, GHz-class NMR and Dynamics Software Enable New Research, and Advance Functional Structural Biology and Drug Discovery BOSTON–(BUSINESS WIRE)–$BRKR #BRKR–At the ICMRBS 2022 Conference, Bruker today announces a new 8 mm 15N TROSY Cryoprobe for enabling novel NMR functional structural biology investigations into larger globular proteins and protein complexes. The new technology … [Read more…]

Presentation by study’s co-author Dr. Kim Papp, a Key Opinion Leader who has completed over 150 studies and worked on numerous drugs now on the market Dr. Papp is designing Can-Fite’s pivotal Phase III psoriasis registration trial PETACH TIKVA, Israel–(BUSINESS WIRE)–Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of … [Read more…]

A review decision by the European Medicines Agency (EMA) is expected in the second half of 2023 If approved, sparsentan will be a first-in-class treatment to address the significant unmet medical need in IgA nephropathy (IgAN) in Europe ST. GALLEN, Switzerland & SAN DIEGO–(BUSINESS WIRE)–CSL Vifor and Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that … [Read more…]